Prev: Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-AnalysisNext: Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome Measure
Record 058 · Systematic review · 2026
Diagnostic performance of anti-DFS70 antibodies in excluding systemic lupus erythematosus diagnosis: An updated systematic review and meta-analysis
Lupus · requested inclusion
“Updated review reports uncertain value of anti-DFS70 alone for excluding lupus, while monospecific anti-DFS70 may be more informative.”
Updated review reports uncertain value of anti-DFS70 alone for excluding lupus, while monospecific anti-DFS70 may be more informative. Limits noted in the record: Distinguishes any anti-DFS70 positivity from monospecific positivity; findings do not support a stand-alone exclusion test. A positive ANA is not a diagnosis. Claims in this record are not verified.
A positive ANA is not a diagnosis. Claims in this record are not verified.
source
- dfs70
- pattern
- lupus
Systematic review
Also in this file
View all in file
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease08.36.E · Lupus
Anti-DFS70 Antibodies for Differentiating Systemic Autoimmune Rheumatic Disease in Patients with Positive ANA Tests: A Systematic Review and Meta-Analysis21.57.X · Diagnostics